30/60
2.5 / 5 stars
All 60 Win/Lose results and 60 gray no-data contests shown below
LFMD Roast Me summary
LifeMD, Inc. (LFMD). Every strict quarterly win earns 1 point. A loss or tie earns 0. A contest with no data is a gray cell, neither a win nor a loss, and leaves the total: stars are 5 × points won ÷ contests with data.
- 2026-Q2: Total return Lose; Revenue growth No data; EPS growth No data.
- 2026-Q1: Total return Win; Revenue growth No data; EPS growth No data.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth No data.
- 2025-Q3: Total return Lose; Revenue growth No data; EPS growth No data.
Trailing 1 year (4 quarters): 2 wins, 3 losses, 7 no dataLast fetched: 24 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/1 |
LoseLFMD / S&P 14.40% / 15.20% |
No dataLFMD / S&P / 15.00% |
No dataLFMD / S&P / 50.40% |
| 2026-Q11/1 |
WinLFMD / S&P 5.87% / -4.33% |
No dataLFMD / S&P / 11.30% |
No dataLFMD / S&P / 27.70% |
| 2025-Q41/2 |
LoseLFMD / S&P -49.78% / 2.65% |
WinLFMD / S&P 25.34% / 9.00% |
No dataLFMD / S&P / 13.40% |
| 2025-Q30/1 |
LoseLFMD / S&P -50.15% / 8.12% |
No dataLFMD / S&P / 4.61% |
No dataLFMD / S&P / 13.45% |
| 2025-Q21/1 |
WinLFMD / S&P 150.37% / 10.94% |
No dataLFMD / S&P / 4.83% |
No dataLFMD / S&P / 10.63% |
| 2025-Q11/1 |
WinLFMD / S&P 9.90% / -4.27% |
No dataLFMD / S&P / 4.98% |
No dataLFMD / S&P / 10.57% |
| 2024-Q40/2 |
LoseLFMD / S&P -5.53% / 2.41% |
LoseLFMD / S&P 1.49% / 5.25% |
No dataLFMD / S&P / 6.15% |
| 2024-Q30/1 |
LoseLFMD / S&P -23.62% / 5.89% |
No dataLFMD / S&P / 5.89% |
No dataLFMD / S&P / 6.11% |
| 2024-Q20/1 |
LoseLFMD / S&P -33.27% / 4.28% |
No dataLFMD / S&P / 5.38% |
No dataLFMD / S&P / 5.12% |
| 2024-Q11/1 |
WinLFMD / S&P 24.00% / 10.56% |
No dataLFMD / S&P / 5.71% |
No dataLFMD / S&P / 5.59% |
| 2023-Q42/2 |
WinLFMD / S&P 32.64% / 11.69% |
WinLFMD / S&P 28.15% / 6.81% |
No dataLFMD / S&P / 7.78% |
| 2023-Q31/1 |
WinLFMD / S&P 43.68% / -3.27% |
No dataLFMD / S&P / 7.52% |
No dataLFMD / S&P / -5.03% |
| 2023-Q21/1 |
WinLFMD / S&P 155.88% / 8.74% |
No dataLFMD / S&P / 9.50% |
No dataLFMD / S&P / -8.57% |
| 2023-Q10/1 |
LoseLFMD / S&P -12.37% / 7.50% |
No dataLFMD / S&P / 10.77% |
No dataLFMD / S&P / -15.69% |
| 2022-Q41/2 |
LoseLFMD / S&P -1.52% / 7.56% |
WinLFMD / S&P 28.16% / 11.88% |
No dataLFMD / S&P / -17.99% |
| 2022-Q31/1 |
WinLFMD / S&P -3.43% / -4.88% |
No dataLFMD / S&P / 13.47% |
No dataLFMD / S&P / -1.41% |
| 2022-Q20/1 |
LoseLFMD / S&P -42.21% / -16.10% |
No dataLFMD / S&P / 13.71% |
No dataLFMD / S&P / 11.04% |
| 2022-Q10/1 |
LoseLFMD / S&P -8.79% / -4.60% |
No dataLFMD / S&P / 15.97% |
No dataLFMD / S&P / 42.23% |
| 2021-Q41/2 |
LoseLFMD / S&P -37.68% / 11.03% |
WinLFMD / S&P 149.04% / 15.00% |
No dataLFMD / S&P / 96.40% |
| 2021-Q30/1 |
LoseLFMD / S&P -47.28% / 0.58% |
No dataLFMD / S&P / 10.77% |
No dataLFMD / S&P / 69.42% |
| 2021-Q20/1 |
LoseLFMD / S&P -25.54% / 8.55% |
No dataLFMD / S&P / 6.58% |
No dataLFMD / S&P / 51.81% |
| 2021-Q11/1 |
WinLFMD / S&P 142.27% / 6.17% |
No dataLFMD / S&P / -1.06% |
No dataLFMD / S&P / 7.39% |
| 2020-Q41/2 |
LoseLFMD / S&P -20.85% / 12.15% |
WinLFMD / S&P 199.10% / -3.72% |
No dataLFMD / S&P / -33.42% |
| 2020-Q31/1 |
WinLFMD / S&P 450.00% / 8.93% |
No dataLFMD / S&P / -2.04% |
No dataLFMD / S&P / -27.10% |
| 2020-Q21/1 |
WinLFMD / S&P 42.86% / 20.54% |
No dataLFMD / S&P / -0.46% |
No dataLFMD / S&P / -27.11% |
| 2020-Q11/1 |
WinLFMD / S&P 75.00% / -19.60% |
No dataLFMD / S&P / 3.47% |
No dataLFMD / S&P / -14.75% |
| 2019-Q41/2 |
LoseLFMD / S&P -29.41% / 9.07% |
WinLFMD / S&P 29227.48% / 5.36% |
No dataLFMD / S&P / 2.99% |
| 2019-Q32/2 |
WinLFMD / S&P 54.55% / 1.70% |
WinLFMD / S&P 71.68% / 5.02% |
No dataLFMD / S&P / 0.21% |
| 2019-Q21/2 |
LoseLFMD / S&P -26.67% / 4.30% |
WinLFMD / S&P 73.93% / 6.64% |
No dataLFMD / S&P / 8.65% |
| 2019-Q11/2 |
LoseLFMD / S&P 7.14% / 13.65% |
WinLFMD / S&P 113.21% / 8.12% |
No dataLFMD / S&P / 14.29% |
| 2018-Q40/2 |
LoseLFMD / S&P -30.00% / -13.52% |
LoseLFMD / S&P -99.15% / 9.05% |
No dataLFMD / S&P / 18.23% |
| 2018-Q31/2 |
LoseLFMD / S&P -9.09% / 7.71% |
WinLFMD / S&P 61.37% / 10.21% |
No dataLFMD / S&P / 19.06% |
| 2018-Q21/2 |
LoseLFMD / S&P -21.43% / 3.43% |
WinLFMD / S&P 81.16% / 9.03% |
No dataLFMD / S&P / 14.46% |
| 2018-Q11/2 |
LoseLFMD / S&P -17.65% / -0.76% |
WinLFMD / S&P 17.29% / 7.68% |
No dataLFMD / S&P / 12.46% |
| 2017-Q40/2 |
LoseLFMD / S&P -20.93% / 6.64% |
LoseLFMD / S&P 0.00% / 7.03% |
No dataLFMD / S&P / 13.82% |
| 2017-Q31/2 |
WinLFMD / S&P 43.33% / 4.48% |
LoseLFMD / S&P -16.44% / 5.68% |
No dataLFMD / S&P / 17.57% |
| 2017-Q20/2 |
LoseLFMD / S&P -40.00% / 3.09% |
LoseLFMD / S&P -9.18% / 4.83% |
No dataLFMD / S&P / 17.74% |
| 2017-Q12/2 |
WinLFMD / S&P 92.31% / 6.07% |
WinLFMD / S&P 46.42% / 3.67% |
No dataLFMD / S&P / 13.32% |
| 2016-Q41/2 |
LoseLFMD / S&P 0.00% / 3.82% |
WinLFMD / S&P 310.22% / 2.09% |
No dataLFMD / S&P / 7.05% |
| 2016-Q31/2 |
LoseLFMD / S&P 0.00% / 3.85% |
WinLFMD / S&P 360.23% / 0.20% |
No dataLFMD / S&P / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | LFMD total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -49.12% | 20.78% |
| Annualized return | -49.12% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | LFMD total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -59.93% | 83.14% |
| Annualized return | -16.71% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | LFMD total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 142.28% | 319.30% |
| Annualized return | 9.25% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-24.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |